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Background: During the last few years, scientific investigations have proposed diet based regimens to prevent
several health ailments including obesity, hypercholesterolemia and diabetes. In this regard, a promising tool is the
use of functional foods/nutraceuticals. Present research project was an attempt to explore nutraceutical worth of
locally grown green tea variety (Qi-Men) against lifestyle related disorders.
Methods: Functional drinks (T2 and T3) were prepared by adding catechins and epigallocatechin gallate (EGCG) @
550 mg/500 mL and compared with control (T1). These functional drinks were tested in experimental rats modeling
(Sprague Dawley). Based on diets, four studies were conducted i.e. trial-I (normal diet), trial-II (high cholesterol diet),
trial-III (high sucrose diet), trial-IV (high cholesterol + high sucrose diet). Rats were monitored daily for their feed
and drink intake while body weight was measured on weekly basis. After period of 56 days rats were sacrificed and
evaluated their serum lipid (cholesterol, LDL and HDL), glucose and insulin levels.
Results: Results for feed consumption by rats revealed that highest feed intake was recorded in group provided
control drink than other groups. However, non significant differences were noted among all groups for drink
consumption. Functional drinks resulted in significant reduction in body weight with maximum lowering noted in
trial-II and III i.e. 10.73 to 8.49% and 10.12 to 10.49%, respectively. Likewise, cholesterol and LDL were substantially
reduced with 14.42% decrease observed in trial-IV and 30.43% in trial-II, respectively. Furthermore, serum glucose
and insulin levels were also lowered significantly in the trial-III and IV while in trial-I and II differences were
non-significant. In contrast to lipid profile, experimental drink containing EGCG reduced the trait better than
catechins based functional drink.
Conclusions: The drinks supplemented with catechins and EGCG are effective against obesity,
hypercholesterolemia and hyperglycemia.
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Changing lifestyle and poor dietary habits of people often
lead to development of various maladies like obesity, dia-
betes, dyslipidemia and immune dysfunction. Obesity is
now well-known as one of the global concerns because it
is not only prevalent in the developed nations but also be-
coming common in the developing world with associated* Correspondence: defeo@unisa.it; ahirzia@gmail.com
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unless otherwise stated.physiological threats. Dyslipidemia is more frequent in
obese people with raised levels of LDL, triglycerides and
cholesterol. Among contributory factors of obesity, dietary
habits are considered one of reasons for its expansion.
During the last few years, amplified consumption of
carbohydrate and animal fat has contributed to increased
incidence of atherosclerosis induced cardiovascular com-
plications and diabetes mellitus. High cholesterol diet
causes significant increase in serum cholesterol level along
with sensitivity to oxidation. Sucrose rich diet induces
hyper-triglyceridemia and hypercholesterolemia [1].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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the ancient times to fight against diseases as most of the
medicines have been derived from plants. In the recent
era, diet based therapy has been revitalized globally and
people are adopting the approach of using natural mate-
rials as an intervention against various ailments. During
the last few years, scientific investigations have proposed
several modules like diet based regimen to prevent life
threatening disorders including obesity, hypercholester-
olemia and diabetes. Among these strategies, a promis-
ing tool is the use of functional/nutraceuticals foods that
not only improve consumer health and wellness but also
reduce disease risk with minimal cost. Green tea (Camellia
sinensis) belonging to family Theaceae is one such example
of functional drinks containing bioactive molecules holding
cure against various diseases. Green tea contains appre-
ciable amounts of phytochemicals especially catechins [2].
According to literature, dried tea leaves mainly contain
10–25% polyphenols mainly belonging to various classes
i.e. flavonols and, flavonoids, and flavondiols. Green tea
catechins are further comprised of different chemical
moieties that inlcue epigallocatechin-3-gallate (EGCG),
epicatechin (EC), epicatechin-3-gallate (ECG), epigallo-
catechin (EGC). Amongst these, EGCG is present in
higher amounts and considered to be an effective anti-
oxidant with appreciable radical scavenging abilities [3].
Owing to the prophylactic role of green tea, its con-
sumption is escalating in the vulnerable segments to
cope with health disorders thus besides being a trad-
itional beverage acts as an intervention against various
physiological threats. Keeping in view the lifestyle disor-
ders, present project was designed to use locally grown
green tea variety Qi-Men with special reference to its ac-
tive ingredient namely catechins. Concurrently, functional
drinks containing the health ingredients i.e. catechins and
EGCG were the limelight of the present research investi-
gation. The therapeutic role of functional drinks was ex-
plored against lifestyle disorders.
Methods
Functional drink preparation
Functional drinks (T2 and T3) were prepared by addition
of catechins and epigallocatechin gallate (EGCG) respect-
ively. A control drink, T1 (without active ingredient) was
also prepared for comparison purpose. Other ingredients
included aspartame, citric acid, sodium benzoate, carboxy
methyl cellulose (CMC), food grade color and flavor. After
processing of drinks, active ingredients including catechins
and EGCG were added individually @ 550 mg/500 mL
in respective drinks. Briefly, catechins rich fraction
from green tea was separated using water at constant
temperature of 40°C and concentrated through a rotary
evaporator (Eyela, Japan) and dried through Vacuum Oven.
Later, chloroform and ethyl acetate were used used toextract catechins from dried extracts. For extracting
EGCG, water filtration followed by addition of caffeine
and subsequent centrifugation at 16,600×g for 20 min
was used. Later, pellet was decaffeinated and solvents
(chloroform and ethyl hexanoate) fractionation was
used for further separation of gallate rich moieties. The
resultant aqueous fraction thus obtained was subjected
to further partition with propyl acetate to get EGCG
rich fraction that was further concentrated using a
Rotary Evaporator and dried using Freeze Drier [4].
Test animals and their housing
The research received ethical approval from Animal Care
Committee (ACC) of National Institute of Food Science
and Technology (NIFSAT). Later, National Institute of
Health (NIH) provided the researchers with 120 infectious
free Sprague dawley rats for the research purpose. The
rats were housed in the Animal Room of National Insti-
tute of Food Science and Technology. Four different trials
depending on different types of diets i.e. trial-I (normal
diet), trial-II (high cholesterol diet), trial-III (high sucrose
diet) and trial-IV (high cholesterol + high sucrose diet)
were conducted. Therfore, 120 rats were divided in four
groups of thirty each. In each trial, rats were further di-
vided into three subgroups comprising of ten rats in each
subgroup. Rats were placed in standard polypropylene
cages with stainless steel top grill. Rats were acclimatized
by feeding basal diet (AIN-76A) for a period of one week.
At the initiation of study some rats were sacrificed to get
baseline values. The temperature (23 ± 2°C) and relative
humidity (55 ± 5%) were maintained throughout the ex-
periment with 12 hours light–dark period. Feed & drink
intake was recorded daily whilst body weight on weekly
basis throughout the experiment. Spilled diet and feces
were also collected.
Trial-I: normal diet
In trial-I normal diet was provided to rats. The normal
diet contained corn oil (10%), casein protein (10%), corn
starch (66%), casein (10%) and cellulose (10%). The min-
eral and vitamin mixtures (AIN-76) were added @ 3% and
1%, respectively. The functional drinks (T1, T2, T3) were
provided in graduated bottles for a period of 8 weeks
(Table 1). Following similar approach, three other studies
were conducted to determine the impact of functional
drinks against respective diets.
Trial-II: high cholesterol diet
In trial-II, high cholesterol diet containing 1% of choles-
terol was distributed to the normal rats along with other
ingredients provided in normal diet. The functional drinks
were also provided to the rats groups simultaneously to
synchronize their effect on the respective category.
Table 1 Diet plan used in the studies
(Trial-I) (Trial-II) (Trial-III) (Trial-IV)
Normal diet High cholesterol diet High sucrose diet High cholesterol + high sucrose diet
Groups 1 2 3 1 2 3 1 2 3 1 2 3
Drinks T1 T2 T3 T1 T2 T3 T1 T2 T3 T1 T2 T3
T1: Control.
T2: Functional drink containing catechins.
T3: Functional drink containing EGCG.
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In trial-III, high sucrose diet containing 40% sucrose was
added to corn oil (10%), corn starch (26%), casein (10%),
cellulose (10%) and salt & vitamin mixture (3 & 1%).
Trial-IV: high cholesterol + high sucrose diet
Rats of group IV were fed on diet including corn oil (10%),
corn starch (25%), casein (10%), cellulose (10%), salt & vita-
min mixture (3 & 1%), cholesterol and sucrose in amount
of 1% and 40% respectively.
The following parameters were recorded separately in
all rat modeling studies.
Feed and drink intake
Net feed intake of each group was measured daily by ex-
cluding spilled diet from the total diet during the entire
study period [5]. The functional drink intake of each
group was also recorded daily by monitoring the differ-
ences in the graduated bottles.
Body weight gain
Gain in body weight of experimental groups was mea-
sured weekly throughout the study period to monitor sup-
pressing effect of functional drinks on body weight gain.
Serum lipid profile
Serum cholesterol level was determined using CHOD–
PAP method [6]. High density lipoprotein (HDL) in serum
samples was measured by HDL Cholesterol Precipitant
method and low density lipoproteins (LDL) following the
procedure of McNamara et al. [7]. Total triglycerides were
determined by liquid triglycerides (GPO–PAP) method [8].
Serum glucose and insulin levels
In each study, rats serum samples were evaluated for
glucose concentration by GOD-PAP method as described
by Thomas and Labor [9] whereas insulin level was
assessed following the method of Besch [10].
Statistical analysis
Completely Randomized Design (CRD) was applied and
resultant data was subjected to statistical analysis using
Cohort version 6.1. Analysis of variance technique(ANOVA) was used to determine the level of significance
and means were further compared through Duncan
Multiple Range test.
Results
Feed and drink intake
Means regarding feed intake (Figure 1) in all trials (I, II,
III and IV) indicated that maximum feed intake was re-
corded in T1 group (control drink). Whereas, compara-
tively, lower feed intakes were noted in T2 (catechins based
functional drink) and T3 (EGCG based functional drink)
groups. In all studies, there was a progressive increase in
feed intake with passage of time however; relatively lower
feed intake was recorded in groups using experimental
functional drinks with green tea active ingredients.
Means belonging to drink intake of rats (Figure 2) in
four studies revealed that there was an increase in drink
consumption during the entire trial with non-significant
differences among the treatments thus showing suitabil-
ity of the product.
Body weights
Body weights of different groups of rats in all studies are
shown in Figure 3 showing that more weight gain was
recorded in rats groups consuming control drink (T1)
than functional drinks (T2 and T3). The trend for body
weights showed differences in each trial e.g. higher body
weights were recorded in high cholesterol fed diets.
Moreover, body weights in all groups increased steadily
in the first 28 days (4 weeks) but last four weeks pro-
vided insight about the differences in body weights. In
all the trials, body weight of rats in experimental groups
was less than placebo or control. The effects of catechins
based functional drinks were more pronounced in high
cholesterol diets, while EGCG based functional drink
performed better in high sucrose diet trial and high
cholesterol + high sucrose diet trial.
Lipid profile
Table 2 showed that functional drink consumption affected
cholesterol significantly in all studies. However drink T2
(drink containing catechins) was more effective in reducing
cholesterol than T3 (drink containing EGCG) though the















































































T1 = Control T2 = Drink containing catechins T3 = Drink containing EGCG 
Figure 1 Feed intake (g/rat/day) to show the effects of functional drinks in different studies fed with diets i.e. normal, high sucrose,
high cholesterol, and high sucrose + high cholesterol. The results were clearly indicating the differences in different trial, however, within
each trial, feed intake varied differently. Normally, feed intake in all the experimental groups remain similar in the first four weeks and later
varied significantly.
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level, while LDL level in different groups of rats was sig-
nificantly affected by functional drinks in all studies. The
values showed non-significant effects of drinks on triglyc-
erides in trial-I and II but significant differences were
recorded for trial-III and IV. Total cholesterol varied from
74.73 ± 2.34 to 78.64 ± 3.07 mg/dL in normal rats, while
the cholesterol level was higher in all other studies. More-
over, it can be observed from the results that functional
drink containing catechins was more effective in reducing
the cholesterol level. However, the percentage reduction
was higher in group of rats fed on high cholesterol diet,
and high cholesterol + high sucrose diets. The trend for
high density lipoproteins was opposite to total cholesterol.
However, the increasing tendency as a function of func-
tional drink was statistically non-significant. The results
regarding low density lipoproteins (LD) indicated that itvaried from 25.55 ± 1.22 to 30.34 ± 1.43 mg/dL in normal
rats, while it was significantly higher in all studies. The
functional drink containing green tea catechins decreased
the trait significantly. However, the reduction was higher in
group of rats fed on high cholesterol diet (30.44%), and
high cholesterol + high sucrose diets (28.81%) in the same
experimental group. In contrast to catechins based func-
tional drink, the EGCG based functional decreased LDL
significantly but its effect was slightly less as compared to
catechins supplemented group. The triglycerides levels
expressed in mg/dL also varied as a functional of experi-
mental diets as mentioned earlier. The level for same trait
was lower in normal rats but significantly higher in groups
of rats fed on cholesterol and sucrose or their combination.
The functional drinks decreased the trait significantly.
Functional drinks containing catechins and EGCG reduced



































































T1 = Control T2 = Drink containing catechins T3 = Drink containing EGCG 
Figure 2 Drink intake (mL/rat/day) to show the effects of functional drinks in different studies fed with diets i.e. normal, high sucrose,
high cholesterol, and high sucrose + high cholesterol. The results showed slight but non-significant variations. It clearly indicates that
functional drinks containing catechins and EGCG remained at par with normal drink.
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reduced the trait by 11.18 and 3.23%, respectively, in high
sucrose fed rats. However, booth drinks performed equally
better in groups of rats fed high cholesterol and high su-
crose diet together i.e. 12.49 and 10.89% reduction in tri-
glycerides, respectively.
Glucose and insulin level
Table 3 also reveals that that treatments exhibited
significant differences on glucose and insulin in the
trial-III and IV while in trial-I and II differences were
non-significant. The results indicated that glucose level
varied from 90.44 ± 4.79 to 93.55 ± 6.01 mg.dL in normal
rats, while in high cholesterol fed rats, the same trait var-
ied from 101.51 ± 4.58 to 105.60 ± 6.61 mg/d. The results
showed some significant glucose lowering abilities of func-
tional drink in group of rats fed on high sucrose or high
cholesterol and sucrose diets. In contrast to lipid profile,
experimental drink containing EGCG reduced the trait
better than catechins based functional drink. Although,variations between functional drinks were statistically
non-significant but higher decrease in glucose levels was
more important. The trait decreased by 10.10 and 12.33%
in catechins and EGCG based functional drinks, respect-
ively. The glucose level decreased by 6.91 and 8.06% in ex-
perimental diets fed on both (cholesterol and sucrose),
respectively. The results regarding insulin showed direct
proportionality with glucose. The decrease in glucose also
witnessed slight decreased amounts of insulin but the de-
crease was more prominent in control groups. Although,
statistically analysis revealed significant variations in insu-
lin but insulin secretions are not influenced quite signifi-
cantly according to researchers point of view. Glucose
lowering properties of functional drinks containing cate-
chins and EGCG could not correlate with insulin but the
effects could be due to their antioxidant nature.
Discussion
In present exploration, less feed consumption due to
















































































T1 = Control T2 = Drink containing catechins T3 = Drink containing EGCG 
Figure 3 Body weight in different studies (g/rat) to show the effects of functional drinks in different studies fed with diets i.e. normal,
high sucrose, high cholesterol, and high sucrose + high cholesterol. The results showed significant variations in different trial. However, the
effects are directly linked with feed intake as higher feed intake results in higher body weight and vice versa.
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of Yang et al. [12]. However, Lee et al. [13] elucidated
suppressed fluid intake in a group provided EGCG solu-
tion. The differences may be due to the fact that they
used EGCG solution without toting up any additive.
However, in the present case drinks were prepared by
adding flavor and artificial sweetener that may be a rea-
son for improved consumption.
The current results showing reduced body weight gain
in groups consuming drinks containing catechins or
EGCG are in consistent with the study of Basu et al. [14]
and Byun et al. [15] Weight reduction by green tea might
be due to reduced digestibility and an increase in energy
expenditure and fat oxidation through β-adrenoceptor ac-
tivated thermogenesis of brown adipose tissue [16,17].
Inhibited lipid absorption from meals might be other rea-
son for reduced weight gain [18].
Results for decreased cholesterol and LDL levels are
in consistent with the work of Kim et al. [19].Hypocholesterolemic potential of catechins can be accre-
dited to increased fecal excretion of cholesterol and bile
acid [20]. Tea catechins increase the bile acid excretion by
preventing reabsorption from small intestine through dis-
ruption of micelle formation of bile acid. This increased
excretion of bile acid and cholesterol activates cholesterol
7α-hydroxylase that enhances the conversion of liver chol-
esterol to bile acid to restock this loss thus resulting in
cholesterol reduction. This decrease in hepatic cholesterol
content in turn stimulates LDL receptor expression and
lowers blood cholesterol level [21].
Results for non-significant effect of drinks on HDL are
in agreement with previous work of Gomikawa et al.
[22]. The effects could be due to presence of various
bioactive components present in green tea [4]. Roghani
and Baluchnejadmojarad [23] noted LDL reduction in
diabetic rat modeling with EGCG. The proposed mechan-
ism of LDL reduction by green tea catechins is through in-
hibition of cholesterol synthesis and dietary cholesterol
Table 2 Effect of functional drinks on lipid profile in rats
Studies Treatments
T1 T2 T3
Cholesterol (mg/dL) Trial-I 78.64 ± 3.07a 74.73 ± 2.34b 76.46 ± 2.42ab
Trial-II 147.02 ± 7.83a 126.42 ± 4.47b 130.09 ± 7.77b
Trial-III 128.74 ± 5.60a 113.84 ± 6.93b 116.79 ± 5.36b
Trial-IV 155.02 ± 8.36a 132.67 ± 6.90b 135.42 ± 6.33b
HDL (mg/dL) Trial-I 34.64 ± 2.57 35.80 ± 1.79 35.47 ± 2.25
Trial-II 56.29 ± 3.71 58.30 ± 4.47 57.80 ± 4.15
Trial-III 46.95 ± 2.59 48.27 ± 3.53 47.80 ± 3.43
Trial-IV 58.86 ± 3.01 60.35 ± 4.66 59.27 ± 2.61
LDL (mg/dL) Trial-I 30.34 ± 1.43a 25.55 ± 1.22b 27.41 ± 1.46ab
Trial-II 69.68 ± 3.45a 48.47 ± 2.41b 52.17 ± 3.79b
Trial-III 64.66 ± 3.22a 50.36 ± 2.83b 52.42 ± 4.32b
Trial-IV 74.59 ± 4.95a 53.10 ± 3.45b 57.27 ± 4.98b
Triglycerides (mg/dL) Trial-I 68.30 ± 3.74 66.92 ± 3.61 67.89 ± 3.13
Trial-II 105.26 ± 6.02 98.23 ± 5.16 100.61 ± 7.71
Trial-III 85.63 ± 6.52a 76.06 ± 5.09b 82.86 ± 4.82ab
Trial-IV 107.85 ± 7.21a 94.38 ± 6.05b 96.10 ± 4.69b
Values are expressed as means ± SD.
Means carrying same letter in a row do not differ significantly.
Means showing different lettering in a row differed significantly at P < 0.05.
Trial-I: Normal diet.
Trial-II: High cholesterol diet.
Trial-III: High sucrose diet.
Trial-IV: High cholesterol + high sucrose diet.
T1: Control drink (without active ingredients).
T2: Drink containing catechins.
T3: Drink containing EGCG.
Table 3 Effect of functional drinks on glucose and insulin levels of rats
Studies Treatments
T1 T2 T3
Glucose (mg/dL) Trial-I 93.55 ± 6.01 92.44 ± 4.43 90.44 ± 4.79
Trial-II 105.60 ± 6.61 103.32 ± 5.26 101.51 ± 4.58
Trial-III 125.93 ± 5.47a 113.21 ± 7.25b 110.40 ± 5.85b
Trial-IV 130.05 ± 8.75a 121.07 ± 7.32b 119.57 ± 6.60b
Insulin (μU/mL) Trial-I 9.33 ± 0.51 9.15 ± 0.68 9.14 ± 0.71
Trial-II 11.05 ± 0.09 10.59 ± 0.15 10.34 ± 0.65
Trial-III 14.34 ± 0.41a 12.65 ± 0.57b 12.20 ± 0.49b
Trial-IV 16.34 ± 0.59a 14.20 ± 0.74b 13.65 ± 0.67b
Values are expressed as means ± SD.
Means carrying same letter in a row do not differ significantly.
Means showing different lettering in a row differed significantly at P < 0.05.
Trial-I: Normal diet.
Trial-II: High cholesterol diet.
Trial-III: High sucrose diet.
Trial-IV: High cholesterol + high sucrose diet.
T1: Control drink (without active ingredients).
T2: Drink containing catechins.
T3: Drink containing EGCG.
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terol concentrations by upregulating LDL receptor. The
increase in the LDL receptor improves the uptake of low
density lipoprotein cholesterol from the blood circulation
[25]. Moreover, reduced expression of 3-hydroxy-3-meth-
ylglutaryl coenzyme A reductase (HMGR) might be an-
other reason for hypocholesterolemic activity of green tea
as green tea EGCG also inhibits HMGR activity [26,27].
Low concentration of triglycerides by green tea might
result from suppressed expression of stearoyl-CoA desa-
turase (SCD 1) gene. Because in liver triglyceride synthe-
sis depends on the expression of the SCD 1 gene, that is
involved in biosynthesis of oleate and palmitoleate, the
major monounsaturated fatty acids of triglycerides. How-
ever, Watanabe et al. [28] is of the view that reduced activ-
ity of acetyl-Co A by green tea catechins is a reason for
low triglycerides synthesis.
Reduced glucose level by green tea is supported by the
work of Polychronopoulos et al. [29] that stated that there
occurs inverse relation between green tea and blood
glucose. The antihyperglycemic effect of green tea may
be due to activated uptake of glucose, inhibited intes-
tinal glucose transporter and decreased expression of
gluconeogenesis controlling genes [30]. EGCG exhibits
hypoglycemic potential by preventing the intestinal glu-
cose absorption via sodium-dependent glucose trans-
porter (SGLT1), lowering the expression of mRNA for
gluconeogenesis controlling enzymes [31] and causing
repression of glucose production, phosphoenolpyruvate
carboxykinase (PEPCK) and glucose-6-phosphatase gene
expression, hepatocyte nuclear factor 1α (HNF1α), and
HNF4α in cells [32]. Additionally, EGCG has direct effect
on hepatic glucose metabolism thus improving glucose
stimulated insulin secretion [32]. Attenuation of insu-
lin level with functional drinks in current exploration
is supported by the work of Hsu et al. [33]. It is
proposed that amelioration of insulin resistance by
green tea is associated with increased expression of
glucose transporter (GLUT) IV [34]. It can be con-
cluded that green tea mitigates hypercholesterolemia
and hyperglycemia effectually. It has cholesterol low-
ering properties along with hypoinsulinemic capability
that could be associated with improved insulin
sensitivity.
Conclusions
Our study demonstrates that drinks supplemented with
catechins and EGCG are effective against obesity, hyper-
cholesterolemia and hyperglycemia. Consumption of func-
tional drink reduced the body weight. Functional drinks
resulted in significant reduction in body weight that could
be caused by a decreased feed intake. Moreover, improve-
ment in lipid profile was observed in all trials but
more pronounced in semi-diseased states i.e. trial-III andtrial-II. Furthermore, serum glucose and insulin levels
were also lowered significantly in the trial-III and IV. It
was interesting to observe that catechins showed higher
potency against hypercholesterolemia but EGCG reduced
the hyperglycemia more effectively.
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